We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Incidence of Thyroid Cancer in 4474 Patients Treated for Hyperthyroidism or Goiter

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01384786
First Posted: June 29, 2011
Last Update Posted: June 29, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Copenhagen University Hospital at Herlev
  Purpose

Patients with hyperthyroidism and/or goiter are evaluated with blood samples and scintiscan before they are treated with radioiodine for their thyroid disease. Because the investigators do not get a histologically/final diagnosis the investigators want to make sure, that the patients treated do not have a thyroid cancer when treated.

The investigators have found that thyroid cancer is not overlooked.


Condition
Hyperthyreosis and Goiter Thyroid Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: The Incidence of Thyroid Cancer in 4474 Patients Treated for Hyperthyroidism or Goiter

Resource links provided by NLM:


Further study details as provided by Copenhagen University Hospital at Herlev:

Enrollment: 4474
Study Start Date: October 2004
Study Completion Date: July 2005
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Radioiodine treated patients
Criteria

Inclusion Criteria:

  • all patients treated with radioiodine
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01384786


Locations
Denmark
herlev Hospital
Copenhagen, Denmark
Sponsors and Collaborators
Copenhagen University Hospital at Herlev
Investigators
Study Chair: Anders Vej-Hansen Herlev Hospital, Copenhagen, Denmark
  More Information

Responsible Party: Birte Nygaard md PhD, dept of endocinology O 106
ClinicalTrials.gov Identifier: NCT01384786     History of Changes
Other Study ID Numbers: JCEM070948
First Submitted: June 28, 2011
First Posted: June 29, 2011
Last Update Posted: June 29, 2011
Last Verified: June 2011

Additional relevant MeSH terms:
Thyroid Diseases
Thyroid Neoplasms
Goiter
Hyperthyroidism
Endocrine System Diseases
Endocrine Gland Neoplasms
Neoplasms by Site
Neoplasms
Head and Neck Neoplasms